Watson Pharm
Article Abstract:
The shares of Watson Pharmaceuticals Inc. have solid price appreciation potential over the 2010-2012 timeframe. The Corona, California-based company offers branded and generic pharmaceutical products and owns a 50% interest in Somerset Pharmaceuticals, a joint venture with Mylan Laboratories.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
OSI Pharma., Inc
Article Abstract:
The price appreciation potential of the shares of OSI Pharmaceuticals Inc. for the years 2010-2012 is discussed. The Melville, New York-based company is engaged in the development and commercialization of drugs for cancer, vision, and diabetes patients.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
User Contributions:
Comment about this article or add new information about this topic: